Lido Advisors LLC purchased a new stake in shares of CME Group Inc (NASDAQ:CME) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 4,303 shares of the financial services provider’s stock, valued at approximately $590,000.

Other hedge funds have also made changes to their positions in the company. Fiduciary Trust Co. bought a new stake in CME Group during the 2nd quarter valued at $105,000. Quadrant Capital Group LLC increased its stake in CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after purchasing an additional 113 shares in the last quarter. San Francisco Sentry Investment Group CA bought a new stake in CME Group during the 2nd quarter valued at $129,000. People s United Financial Inc. increased its stake in CME Group by 11.5% during the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 110 shares in the last quarter. Finally, Mckinley Capital Management LLC Delaware bought a new stake in CME Group during the 2nd quarter valued at $150,000. Institutional investors and hedge funds own 83.17% of the company’s stock.

Shares of CME Group Inc (NASDAQ CME) opened at $153.41 on Tuesday. CME Group Inc has a one year low of $113.27 and a one year high of $154.03. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. The stock has a market cap of $51,960.00, a price-to-earnings ratio of 31.55, a PEG ratio of 3.10 and a beta of 0.73.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The firm had revenue of $890.80 million during the quarter, compared to analyst estimates of $890.22 million. During the same quarter in the prior year, the business posted $1.05 EPS. The business’s revenue was up 5.8% compared to the same quarter last year. research analysts expect that CME Group Inc will post 4.78 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date of this dividend is Thursday, December 7th. CME Group’s dividend payout ratio (DPR) is currently 59.86%.

Several research firms have recently issued reports on CME. Barclays upped their target price on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 10th. Wells Fargo & Company upped their target price on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research note on Wednesday, October 4th. Royal Bank Of Canada upped their target price on shares of CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a research note on Monday, October 16th. Citigroup upped their target price on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, October 19th. Finally, BidaskClub lowered shares of CME Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and seven have issued a buy rating to the company’s stock. CME Group currently has a consensus rating of “Buy” and an average price target of $141.75.

In related news, COO Julie Holzrichter sold 12,920 shares of the business’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $144.08, for a total value of $1,861,513.60. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 714 shares of the business’s stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $129.00, for a total transaction of $92,106.00. Following the completion of the transaction, the insider now directly owns 28,844 shares in the company, valued at $3,720,876. The disclosure for this sale can be found here. Insiders sold a total of 35,635 shares of company stock worth $5,108,354 over the last three months. 0.57% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: This news story was first published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://theolympiareport.com/2017/12/05/lido-advisors-llc-invests-590000-in-cme-group-inc-cme-stock.html.

CME Group Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.